Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Fui Leng Yan"'
Autor:
Foong Ying Wong, Natalia Liem, Chen Xie, Fui Leng Yan, Wing Cheong Wong, Lingzhi Wang, Wei-Peng Yong
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e50786 (2012)
Although gemcitabine is highly active in several cancer types, intrinsic and acquired drug resistance remains a major challenge. Overexpression of Bcl-2 has been associated with gemcitabine resistance. The aim of this study is to determine whether go
Externí odkaz:
https://doaj.org/article/f5c5027d887e4efabdbe7242f902ef83
Autor:
Wei Peng Yong, Vaidehi Krishnan, Natalia Liem, Praveen C. Peethala, Fui Leng Yan, Mei Shi Yeo, Shi Hui Tan, Vinod Vijay Subhash
Table S1. Primers used to amplify ATM gene; Figure S1. siRNA knock down of ATM in HGC 27 cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3aa776843d46e11e58dc84836c9d7968
https://doi.org/10.1158/1535-7163.22508752
https://doi.org/10.1158/1535-7163.22508752
Autor:
Wei Peng Yong, Shi Hui Tan, Fui Leng Yan, Mei Shi Yeo, Praveen C. Peethala, Natalia Liem, Vaidehi Krishnan, Vinod Vijay Subhash
Publikováno v:
Molecular cancer therapeutics. 15(12)
Identification of synthetically lethal cellular targets and synergistic drug combinations is important in cancer chemotherapy as they help to overcome treatment resistance and increase efficacy. The Ataxia Telangiectasia Mutated (ATM) kinase is a nuc
Publikováno v:
Journal of Carcinogenesis & Mutagenesis.
Melanoma Associated Antigen (MAGE)-encoding genes have been shown to be aberrantly expressed in various tumour types, and correlate with tumour progression and resistance to docetaxel. The objective of this study was to elucidate the regulatory mecha
Autor:
Fui Leng Yan, Lingzhi Wang, Wei Peng Yong, Foong Ying Wong, Chen Xie, Natalia Liem, Wing-Cheong Wong
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 12, p e50786 (2012)
PLoS ONE, Vol 7, Iss 12, p e50786 (2012)
Although gemcitabine is highly active in several cancer types, intrinsic and acquired drug resistance remains a major challenge. Overexpression of Bcl-2 has been associated with gemcitabine resistance. The aim of this study is to determine whether go
Publikováno v:
Cancer Research. 76:4937-4937
Background: Identification of synthetically lethal cellular targets and synergistic drug combinations are important in cancer chemo therapy as they help to overcome treatment resistance and increase efficacy. The Ataxia Telangiectasia Mutated (ATM) k